Employees: 46,000

Employee growth: 0.0%

The health care unit of diversified giant General Electric, GE Healthcare is a leading maker of
diagnostic imaging equipment, such as MRI, ultrasound, and computed tomography (CT) scanners.
And while such imaging is the unit's main offering, it has its fingers in other medical equipment
pies as well. It makes surgical and clinical scanning and monitoring systems (such as ECG and
ultrasound monitors), as well as contrast agents (dyes) used in imaging procedures. GE Healthcare
also develops life sciences technology for drug discovery, makes clinical and financial management
software for health care providers, and provides a range of services from consulting to equipment
financing for hospitals.

Key numbers for fiscal year ending December, 2008:

Sales: $17,300.0M
One year growth: 2.4%
Officers:
President and CEO: John M. Dineen
General Manager Global Sourcing and Operations: Raphael (Ralph) Strosin
EVP and CIO: Russel P. (Russ) Mayer
Competitors:
Philips Healthcare
Siemens Healthcare
Toshiba

GE Healthcare is a unit of GE Technology Infrastructure[1], which is a unit of General Electric

(GE). It employs more than 46,000 people worldwide and is headquartered in Little Chalfont,
Buckinghamshire, United Kingdom. The CEO of GE Healthcare is John Dineen. GE Healthcare is
the first GE business segment headquartered outside the United States. In 2004, just before the
completion of the $9 billion acquisition of U.K.-based Amersham plc, the formerly named GE
Medical Systems was renamed GE Healthcare.

GE Healthcare is a unit of GE Technology Infrastructure[1], which is a unit of General Electric

(GE). It employs more than 46,000 people worldwide and is headquartered in Little Chalfont,
Buckinghamshire, United Kingdom. The CEO of GE Healthcare is John Dineen. GE Healthcare is
the first GE business segment headquartered outside the United States. In 2004, just before the
completion of the $9 billion acquisition of U.K.-based Amersham plc, the formerly named GE
Medical Systems was renamed GE Healthcare.

Overview
GE Healthcare has a range of products and services that include medical imaging and information
technologies, medical diagnostics, patient monitoring systems, drug discovery, and
biopharmaceutical manufacturing technologies.
From a brief period from the close of the Amersham acquisition in April 2004 - June 2005, GE
Healthcare was organized into two primary business segments: GE Healthcare Technologies, led by
Joseph Hogan, and GE Healthcare Bio-Sciences, the former Amersham business segments that were
led by Peter Löscher. Those business segment names and organizations were formally dropped in
June 2005.

Business units
GE Healthcare currently has 6 primary business units:
• GE Healthcare Global Diagnostic Imaging, headquartered in Waukesha (near Milwaukee),
Wisconsin, USA. The Diagnostic Imaging business includes X-ray, digital mammography,
Computed Tomography (CT), Magnetic Resonance (MR) and Molecular Imaging
technologies.
• GE Healthcare Clinical Systems, headquartered in Wauwatosa (suburb of Milwaukee),
Wisconsin, USA. This business provides a range of healthcare technologies and services for
clinicians and healthcare administrators. It includes ultrasound, ECG, bone densitometry,
patient monitoring, incubators and infant warmers, respiratory care and anesthesia
management. In collaboration with GE Healthcare, The Wayne State University School of
Medicine offers an integrated radiology curriculum during its MD Program led by
investigators of the Advanced Diagnostic Ultrasound in Microgravity study. [2] GE has
donated over one million dollars of Logiq E Ultrasound equipment for this study. [3]
• GE Healthcare IT, headquartered in Barrington, Illinois, USA. [4] Healthcare IT provides
clinical & financial information technology solutions such as departmental IT products,
RIS/PACS (Radiology Information Systems/Picture Archiving and Communication
Systems) and CVIS (Cardiovascular Information Systems), as well as revenue cycle
management and practice applications.
• GE Healthcare Medical Diagnostics, headquartered in Little Chalfont, Buckinghamshire,
UKA. Medical Diagnostics researches, manufactures and markets imaging agents used
during medical scanning procedures to highlight organs, tissue and functions inside the
human body.
• GE Healthcare Life Sciences, headquartered in Uppsala, Sweden. This division produces
technology for drug discovery, biopharmaceutical manufacturing and cellular technologies.
It also makes systems and equipment for the purification of biopharmaceuticals.
• GE Healthcare Surgery, headquartered in Salt Lake City, Utah, USA. This provides tools
and technologies for cardiac, surgical and interventional care, from cardiac catheterization
labs, diagnostic monitoring systems, data management systems to mobile fluoroscopic
imaging systems, navigation and 3D visualization instrumentation.
While it has offices around the globe, GE Healthcare has major regional operations in Buc (suburb
of Paris), France; Budaors(suburb of Budapest), Hungary;Hino & Tokyo, Japan; Helsinki, Finland;
and Bangalore, India.

History
In 1893 C.F. Samms and J.B. Wantz[5] were making dental engines and beer pumps, and by
October 1895 had a staff of 6 in a 30 square meter basement and a capital of $3,000 invested in
Victor Electric Co.
Victor Electric[6] plunged into the x-ray business and by 1896 (one year after Roentgen’s
discovery) were making x-ray machines. The business grew rapidly and so, in 1896, moved into
new premises three times the original size, but this did not solve the space problems and the
company made 3 moves by 1899.
Victor Electric had competitors. In 1896 a G.A.Frye began making x-ray tubes and in 1897, that
business was purchased by Swett & Lewis, and the first merger in the x-ray business had started.
During the first years, it was easier to keep up with the competition than space requirements. By
1903, Victor Electric had outgrown its facilities at 418 Dearborn St. in Chicago and bought two
floors of a building at 55 Market Street, Chicago. This was again only a temporary stop; by 1910 it
was too small and the firm moved again in 1911 to a building at the corner of Jackson Blvd. and
Damon Avenue. This was the first permanent home of Victor Electric Co. They stayed there 35
years and during this time, gradually acquired all the space in the building and several around it.
During the first 20 years of the x-ray business, many new names appeared. In 1901 the Western
Electric Coil Co. was formed. In 1902 MacAlaster & Wiggin purchased the x-ray tube business of
Swett & Lewis. Two other companies were the Radio Electric Co., which was later to be known as
Snook-Roentgen Manufacturing and the Scheidel Western X-Ray Coil Co.
In 1916, the first significant merger took place, Scheidel Western, Snook-Roentgen, MacAlaster &
Wiggin, and Victor Electric Co. were merged with Victor, the surviving name. Victor’s two founders
had key roles in the new firm; C.F.Samms was president and J.B.Wantz was Vice-President of
manufacturing and engineering.
Four years later, in 1920, a second major merger was accomplished as Victor was partially acquired
by General Electric which was, at that time, the foremost manufacturer of x-ray tubes.
The marriage of Victor Electric and General Electric became complete of July 28th, 1926 when
Victor was declared a wholly owned affiliate of General Electric. The merger brought renewed
vitality to the organization and Victor entered the foreign market with equipment sold and serviced
in nearly 70 countries. In 1930, the name was changed from Victor to General Electric X-Ray
Corporation.
World war II saw the dramatic use of x-rays in industry for non-destructive testing of war materials.
It also saw the broad use of x-rays as a medical tool for military services.
As the war ended, GE X-Ray Corporation’s growth did not; it soon became evident that more space
was needed and it was time to leave Jackson Blvd. Chicago. In Milwaukee was a 43 acre site which
had been used for building turbochargers during the war. The street in front was renamed Electric
Avenue, and the General Electric X-Ray Corporation had a new home in 1947.
In 1951, the corporate structure was dissolved and the name changed to General Electric x-Ray
Department. This new name lasted less than 10 years as the department divested itself of its
industrial x-ray business, widened its medical business, and took on the name of GE Medical
Systems Department. One of the reasons for the name of Medical Systems was due to the increase
in the electro-medical business, which began in 1961 with the introduction of patient monitoring
equipment. By 1967 modular equipment was developed which was soon popular in cardiac and
intensive care units. Early in 1960, pacemakers were developed in Corporate Research &
Development in Schenectady, and in 1969 the Standby Pacemaker was developed.
In 1968, the Biomedical Business Section opened its first factory in Egerton Avenue. Late in 1970 a
surgical package was introduced and in 1971, equipment to monitor blood gasses during surgery
was introduced.
Later in 1971, Biomedical opened a 9,000 square meter admin and engineering building opposite its
factory and in 1972, the section was renamed The cardio-Surgical Product Section. With the growth
of its medical business, the General Electric Company upgraded the department to The Medical
Systems Division in 1971. Also in 1971, a major expansion programme was started and the
Waukesha factory was planned. Work started in July 1972, ansd was completed in 1973.
In 1973, work on CT was started and eventually the first CT was installed in 1976, and
development went on to the first CT 8800, and after long negotiations, the medical division of EMI
was acquired in late 1980. The Americal Anti-Trust Authorities stopped the takeover in the USA
however, and the EMI factory in Chicago was bought up by Omni-Medical, who continued to make
CTs for a number of years.
Meanwhile, back at GE, the patient Monitoring Dept. was sold off in 1981. The initial boost
provided by the EMI takeover turned into the doldrums as Reaganomics sent the US dollar soaring,
so in 1984 GE bought a 49% share of YMS (Yokogawa Medical Systems) a Japanese company.
YMS proceeded to produce high quality low cost diagnostic equipment for the world market with
astounding energy, producing new CT models with a speed that was and is hard to match.
In 1983 GE Medical started investing heavily in Magnetic Resonance Imaging (MR) technology,
investing nearly 1 billion US dollars in a new plant in Waukesha, and the MR Signa was born,
which would go on to become the very successful MR model range. The magnet plant in Florence
(USA) was opened a short time later, giving GE its own magnet production.
In 1985 GE acquired Technicare from Johnson and Johnson. Originally named Ohio Nuclear, and in
1979, after another fusion, Ohio Nuclear Unirad, the name was changed to Technicare in 1982.
Technicare (with headquarters in Cleveland Ohio) had been producing a range of rotate-stationary
CTs with an installed base in the thousands, as well as some x-ray diagnostic equipment and a
nascent MR product range.
Up to this time the medical Systems Division had simply been divided into domestic and
international, but in 1987 it was decided to re-organize into the three “poles” of America, Europe
and Pacific. In 1988 GE Medical Europe merged with CGR (a medical equipment supplier based in
France) to form General Electric CGR Medical Systems. The European headquarters were moved
from Hammersmith (UK) to Buc near Paris.
In 1992, GE had a setback after long negotiations to buy Picker International, who were a major
producer of CT and MR equipment, The deal was not approved by the American authorities, and so
GE just bought the Picker Service organization in the U.K., leaving the rest of Picker intact.
In 1994 it was decided to change the name in Europe from GE-CGR back to General Electric
Medical Systems. At the close of 1998 GE Medical acquired the Nuclear and MR businesses of
Elscint, (based in Haifa, Israel), the CT business being bought by Picker, and in the same year
Marquette Medical Systems became a wholly owned subsidiary of GE Medical. In 1998 GE
medical bought Diasonics Vingmed Ltd. from Elbit Imaging (Haifa Israel), thus expanding its
ultrasound imaging business.
In 2003, GE Healthcare acquired Instrumentarium (including its Datex-Ohmeda division), a
producer, manufacturer, and supplier of anesthesia machines and mechanical ventilators. To satisfy
regulatory concerns in the United States and in Europe, GE Healthcare was forced to divest the
Spacelabs Medical division of Instrumentarium. Currently, GE Healthcare owns 80% of all
anesthesia machines in the United States and 60% of the machines in the world. The former
Instrumentarium business was incorporated into GE Healthcare's Clinical Systems business
segment.
In 2004, the former Amersham plc business segments were separated into the GE Healthcare
Medical Diagnostics and Life Sciences business segments.
Also in 2004, GE Healthcare along with other healthcare companies built a research reactor for
neutron and unit cell research at GE's European Research Center near Garching (outside of
Munich), Germany. It is the only such reactor currently in operation.
In 2005, Sir William Castell, CEO of GE Healthcare and former CEO of Amersham plc stepped
down as CEO to become Chairman of the Wellcome Trust -- a charity that fosters and promotes
human and animal research -- in the United Kingdom. Former GE Medical Systems CEO Joe
Hogan became the overall CEO for the GE Healthcare business.
In 2005, Dental Imaging operations were separated from GE Healthcare. The PaloDEx Group Oy
was founded and continues the business with its subsidiaries Instrumentarium Dental and
SOREDEX. Specifically, Instrumentarium Dental continues the brands Orthopantomograph and
intraoral systems FOCUS and SIGMA, formerly known as Instrumentarium Imaging or GE
Healthcare products.[7][8]
In September 2005, GE Healthcare and IDX Systems Corporation announced that they entered into
a definitive, $1.2 billion merger agreement for GE to acquire IDX, a leading healthcare information
technology (IT) provider. The acquisition was completed in January 2006. IDX was folded into GE
Healthcare Integrated IT Solutions, which specializes in clinical information systems and healthcare
revenue management.
On 4 February 2008, GE Healthcare announced that it has completed the acquisition of Whatman
plc (LSE:WHM) , a global supplier of filtration products and technologies at 270p per share in cash
for each Whatman share, valuing Whatman at approximately £363 million (approximately $713
million.)
In July 2008, Joseph Hogan announced his intent to leave his post as CEO of GE Healthcare to take
the role of CEO at ABB.[9]
On July 17, 2008, GE Healthcare announced John Dineen had been chosen to replace outgoing
CEO Joseph Hogan. Mr. Dineen had been head of GE's Transportation division since 2005.

Management
• President and CEO: John Dineen
• President and CEO, Global Diagnostic Imaging Mark Vachon
• President and CEO, Integrated IT Solutions Vishal Wanchoo
• President and CEO, Clinical Systems Omar Ishrak
• President and CEO, Life Sciences Peter Ehrenheim
• President and CEO, Medical Diagnostics Pascale Witz
• CEO, Surgery Peter McCabe

Competition
Some major competitors of GE Healthcare are Siemens Medical Solutions, Agfa, Philips,
MAQUET and Toshiba.
GE Healthcare provides transformational medical technologies and services that are shaping a new
age of patient care. Our broad expertise in medical imaging and information technologies, medical
diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing
technologies, performance improvement and performance solutions services help our customers to
deliver better care to more people around the world at a lower cost. In addition, we partner with
healthcare leaders, striving to leverage the global policy change necessary to implement a
successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we
continuously develop innovations focused on reducing costs, increasing access and improving
quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a
$17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs
more than 46,000 people committed to serving healthcare professionals and their patients in more
than 100 countries. For more information about GE Healthcare, visit our website at
www.gehealthcare.com.

Financial Highlights

2006 Revenues: $16.6 billion

2007 Revenues: $16.9 billion
2008 Revenues: $17.3 billion

Research & Development Expenditures: ~$1 billion

Our Vision

At GE Healthcare, we strive to see life more clearly. Our purpose is to help healthcare providers
predict, diagnose, inform, monitor and treat disease earlier so that every individual can live life to
the fullest. Our vision for the future is to enable a new “early health” model of care focused on
earlier diagnosis, pre-symptomatic disease detection and disease prevention.

In an effort to make even greater strides toward realizing this vision, GE Healthcare recently
realigned its operating structure into five product P&Ls and five regional P&Ls, divided by
geography.

GE Healthcare Regional P&Ls

• Americas
• Asia-Pacific
• China
 • EMEA
• India

GE Healthcare Product P&Ls

GE Healthcare’s Surgery business offers a broad range of market-leading intra-operative and

interventional imaging products, from a specialized mini C-arm for extremity imaging to cost-
effective full-sized C-arms. Surgery's imaging products are integral in many fields including
general surgery, orthopedics, neurosurgery, urology, cardiology, and GI, and for specialized
procedures such as pain management. Surgery prides itself on offering imaging products with
superb image quality and an unparalleled technical and clinical support team that ensures the
products deliver optimum performance.

GE Healthcare’s Healthcare Systems business provides a wide range of technologies and services
for clinicians and healthcare administrators that can help caregivers improve the consistency,
quality and efficiency of patient care everywhere. These technologies help provide a fast, non-
invasive way for doctors to see broken bones, diagnose trauma cases in the ER, view the heart and
its function, or identifying the early stages of cancers or brain disorders. With X-ray, digital
mammography, Computed Tomography (CT), Magnetic Resonance (MR) and Molecular Imaging
technologies, GE creates industry-leading products that allow clinicians to see inside the human
body more clearly than ever. In addition, with efforts in ultrasound, ECG, bone densitometry,
patient monitoring, interventional imaging, incubators and infant warmers, respiratory care,
anesthesia management and a wide range of technologies and services for clinicians and healthcare
administrators, GE’s Healthcare Systems business enables clinicians to provide better care for
millions of patients every day - from wellness screening to advanced diagnostics to life-saving
treatment.

GE Healthcare’s Life Sciences business delivers breakthroughs in drug discovery,

biopharmaceutical manufacturing and the latest in cellular technologies, so scientists and
specialists around the world discover new ways to predict, diagnose and treat disease earlier. The
Life Sciences business also makes systems and equipment for the purification of
biopharmaceuticals.

GE Healthcare’s Medical Diagnostics business researches, manufactures and markets innovative

imaging agents used during medical scanning procedures to highlight organs, tissue and functions
inside the human body, to aid physicians in the early detection, diagnosis and management of
disease.

GE Healthcare’s Healthcare IT business provides comprehensive clinical & financial information

technology solutions including enterprise and departmental Information Technology products,
RIS/PACS and CVIS systems, revenue cycle management and practice applications, to help
customers streamline healthcare costs and improve the quality of care.

GE’s involvement in key care areas:

Cardiology
Cardiovascular disease refers to any disease, relating to the blood vessels. This includes coronary
heart disease (including heart attacks) and cerebrovascular disease (problems relating to the blood
supply to the brain, including stroke and brain haemorrhage).

Advances in diagnostic tools, targeted therapies and IT-based disease management hold the
potential to change the course of cardiovascular disease, as we know it today.

Integrated Cardiac Solutions from GE Healthcare transform how doctors predict, diagnose, inform
and treat heart disease.

Neurology

Neurologists advancing understanding of function and disease in the central nervous system rely
heavily on modern medical imaging, from magnetic resonance imaging (MRI), to computed
tomography (CT), positron emission tomography (PET) and single photon emission computed
tomography (SPECT). These technologies are providing ever better insight into diseases that affect
and degrade the functioning of the brain and the central nervous system; so called
neurodegenerative diseases.

GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics,

patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies is
helping physicians develop new ways to predict, diagnose, monitor and inform about brain disease,
from Dementia and Alzheimer’s to Parkinson’s Disease and Stroke.

Emergency Medicine

GE Healthcare has a comprehensive portfolio of Emergency Medicine solutions and products that
can empower customers to transform patient care. Our offering gives Emergency Department
clinicians and Directors patient-oriented tools and information that enable them to consistently
work faster and help improve quality of care. GE Healthcare has a unique combination of products
and services to offer customers clinical excellence, technology leadership and industry expertise.

Oncology

PET/CT, CT, MR, mammography and ultrasound are all key components of GE Healthcare’s
involvement in the field of oncology, guided by our Molecular Imaging business. Molecular
Imaging uses sophisticated diagnostic imaging equipment and systems to visualize specific ‘signal
molecules’, based on their chemical and biological properties. This enables physicians to peer into
the living body in to identify diseases, monitor their progression or treat medical conditions at a
molecular level.

Molecular imaging has three key applications:

• Localizing and identifying diseases, possibly even before the symptoms appear.
• Providing an understanding of treatment effectiveness for precision treatment planning by
monitoring response.
• Helping the pharmaceutical industry with information-driven patient selection by
identifying individuals and subpopulations in which a drug is more likely to be effective,
safe and well-tolerated, which could tip the balance in favor of successful trial outcomes,
and with imaging based drug development tools.
Women’s Health

GE Healthcare provides a broad, technologically advanced portfolio across the spectrum of female-
specific conditions. We are committed to developing technologies that enable earlier detection,
more accurate diagnoses and personalized treatment plans for women affected by cancer, heart
disease, stroke and other conditions.

Bone Health: An integral part of a woman's overall well-being. Bone densitometry can play and
important role in early detection and monitoring progression of bone loss. GE Healthcare offers
options for in-office and portable densitometry systems as part of an overall bone health program.

Breast Health: Whether delivering screening exams or a complete breast care continuum, GE
Healthcare provides the most technologically advanced tools available to the field. Bringing
together world-class expertise in the biosciences, medical imaging, information technology and
workflow optimization, GE Healthcare can help optimize patient care from screening and
diagnostics through treatment and therapy monitoring.

Heart Health: Heart disease is the #1 killer of women globally. Catching heart disease early is
critical especially for women that may not exhibit traditionally recognized symptoms. At GE
Healthcare we are committed to a gender-specific approach to the prevention of cardiovascular
disease, and to the development of innovative technologies that help doctors diagnose and treat
their female patients.

OB/Gyn Health: Obstetrical care is often the first in-patient experience for a woman and can lead
to a life-long relationship with a care provider. GE Healthcare understands the importance of
Obstetrics and Gynecologic care to a Woman's Health program by providing industry leading
ultrasound technologies, unique therapeutic solutions for the treatment of uterine fibroids and
world-class devices for perinatal and post-natal care.

At GE Healthcare, we strive to see life more clearly. We help predict, diagnose, inform, and treat,
so that every individual can live life to the fullest.

GE Healthcare is committed to serve the communities where we do business to provide our

customers with innovative, high-quality products and services and to protect the health of our
workers and our environment.

• Contact

Social Performance
We are committed to being a responsible and caring member of the communities where we operate,
and to providing good working conditions and opportunities for employees.

Environment
We are committed to integrating environmental and social issues into our business.

• Environmental Regulations
• EU Battery Directive (in Bulgarian)
• EU Battery Directive (in Czech)
• EU Battery Directive (in Estonian)
• EU Battery Directive (in Latvian)
• EU Battery Directive (in Lithuanian)
• EU Battery Directive (in Maltese)
• EU Battery Directive (in Portuguese)
• EU Battery Directive (in Slovak)
• EU Battery Directive (in Slovenian)

Quality
To improve the quality of your healthcare departments, we suggest the use of an initiative
developed by General Electric: Six Sigma methodology, which we now make available to all our
partners in the medical world.

Innovation
From jet engines to power generation, financial services to plastics, and television to medical
imaging, GE people are dedicated to turning good ideas into technologies that make the world a
better place. Backed by its Global Research Center, with more than 100 years of innovative
breakthroughs, GE will increase the number of new products introduced by 25%.

Strengths
• Diversified business portfolio
• Strong research & development (R&D)
• Order backlog guarantees business flow in the future
• Strong management & culture in terms of people, systems, technology and measures

Weaknesses
• Bets on financial markets have proven unsuccessful with economic turmoil
• Weak revenue growth of industrial segment
• Underperforming in Asian markets
• Leveraged
Opportunities
* Development of infrastructure
* Aviation industry growth
* Increasing global exploration and production
* Servicing and regeneration of commercial airplanes around the world

Threats
• Senior management - weak performance by GE has put doubts on Jeff Immelt's ability to be
the next Jack Welch
• Rising commodity prices
• Exposure to financial markets
• World economic slowdown in the US and Eurozone, two of the most important markets for
GE